{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:05:30Z","timestamp":1790816730244,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK093821"],"award-info":[{"award-number":["DK093821"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006792","name":"Hartwell Foundation","doi-asserted-by":"publisher","award":["AG043822"],"award-info":[{"award-number":["AG043822"]}],"id":[{"id":"10.13039\/100006792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006792","name":"Hartwell Foundation","doi-asserted-by":"publisher","award":["HL116848"],"award-info":[{"award-number":["HL116848"]}],"id":[{"id":"10.13039\/100006792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.yjmcc.2014.05.002","type":"journal-article","created":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T10:46:36Z","timestamp":1400064396000},"page":"98-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["BET-ting on chromatin-based therapeutics for heart failure"],"prefix":"10.1016","volume":"74","author":[{"given":"Saptarsi M.","family":"Haldar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy A.","family":"McKinsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2014.05.002_bb0005","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1152\/physiolgenomics.00040.2004","article-title":"Microarray analysis of gene expression after transverse aortic constriction in mice","volume":"19","author":"Zhao","year":"2004","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0010","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/CIRCULATIONAHA.106.632430","article-title":"Transcriptional genomics associates FOX transcription factors with human heart failure","volume":"114","author":"Hannenhalli","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1172\/JCI62839","article-title":"Signaling effectors underlying pathologic growth and remodeling of the heart","volume":"123","author":"van Berlo","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0020","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.cell.2013.02.014","article-title":"Transcriptional regulation and its misregulation in disease","volume":"152","author":"Lee","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0025","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature12751","article-title":"Chromatin proteins and modifications as drug targets","volume":"502","author":"Helin","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0030","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/cr.2011.32","article-title":"ATP-dependent chromatin remodeling: genetics, genomics and mechanisms","volume":"21","author":"Hargreaves","year":"2011","journal-title":"Cell Res"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0035","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/38444","article-title":"Crystal structure of the nucleosome core particle at 2.8 A resolution","volume":"389","author":"Luger","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrg2905","article-title":"Charting histone modifications and the functional organization of mammalian genomes","volume":"12","author":"Zhou","year":"2011","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0045","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0092-8674(02)01196-0","article-title":"Signaling network model of chromatin","volume":"111","author":"Schreiber","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0050","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/embor.2012.52","article-title":"Enhancers: emerging roles in cell fate specification","volume":"13","author":"Ong","year":"2012","journal-title":"EMBO Rep"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0055","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrg3207","article-title":"Transcription factors: from enhancer binding to developmental control","volume":"13","author":"Spitz","year":"2012","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.gde.2011.11.001","article-title":"Enhancer and promoter interactions-long distance calls","volume":"22","author":"Krivega","year":"2012","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0065","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.sbi.2007.12.002","article-title":"The enhanceosome","volume":"18","author":"Panne","year":"2008","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0070","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nrg2847","article-title":"Unexpected roles for core promoter recognition factors in cell-type-specific transcription and gene regulation","volume":"11","author":"Goodrich","year":"2010","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0075","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/cr.2011.22","article-title":"Regulation of chromatin by histone modifications","volume":"21","author":"Bannister","year":"2011","journal-title":"Cell Res"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0080","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2013.09.011","article-title":"Mapping human epigenomes","volume":"155","author":"Rivera","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0085","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nrg3293","article-title":"Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans","volume":"13","author":"Adelman","year":"2012","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0090","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature08449","article-title":"Defining mechanisms that regulate RNA polymerase II transcription in vivo","volume":"461","author":"Fuda","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0095","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nrg2901","article-title":"The metazoan mediator co-activator complex as an integrative hub for transcriptional regulation","volume":"11","author":"Malik","year":"2010","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0100","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev-biochem-052610-095910","article-title":"RNA polymerase II elongation control","volume":"81","author":"Zhou","year":"2012","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0105","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.cell.2013.07.013","article-title":"BET bromodomains mediate transcriptional pause release in heart failure","volume":"154","author":"Anand","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0110","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/nm778","article-title":"Activation and function of cyclin T-Cdk9 (positive transcription elongation factor-b) in cardiac muscle-cell hypertrophy","volume":"8","author":"Sano","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0115","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1126\/science.1229386","article-title":"Precise maps of RNA polymerase reveal how promoters direct initiation and pausing","volume":"339","author":"Kwak","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0120","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.gpb.2013.05.001","article-title":"A brief review on the human encyclopedia of DNA elements (ENCODE) project","volume":"11","author":"Qu","year":"2013","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0125","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1126\/science.1222794","article-title":"Systematic localization of common disease-associated variation in regulatory DNA","volume":"337","author":"Maurano","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0130","doi-asserted-by":"crossref","first-page":"20164","DOI":"10.1073\/pnas.1315155110","article-title":"Genome-wide analysis of histone marks identifying an epigenetic signature of promoters and enhancers underlying cardiac hypertrophy","volume":"110","author":"Papait","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0135","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.cell.2012.07.035","article-title":"Dynamic and coordinated epigenetic regulation of developmental transitions in the cardiac lineage","volume":"151","author":"Wamstad","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0140","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.cell.2013.07.011","article-title":"Mechanisms and functions of ATP-dependent chromatin-remodeling enzymes","volume":"154","author":"Narlikar","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0145","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1146\/annurev-physiol-020911-153242","article-title":"Epigenetics and cardiovascular development","volume":"74","author":"Chang","year":"2012","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0150","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1101\/gad.207415.112","article-title":"BAF60 A, B, and Cs of muscle determination and renewal","volume":"26","author":"Puri","year":"2012","journal-title":"Genes Dev"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0155","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nature09130","article-title":"Chromatin regulation by Brg1 underlies heart muscle development and disease","volume":"466","author":"Hang","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0160","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1101\/gr.121145.111","article-title":"Regulation of nucleosome landscape and transcription factor targeting at tissue-specific enhancers by BRG1","volume":"21","author":"Hu","year":"2011","journal-title":"Genome Res"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0165","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1161\/01.RES.0000146675.88354.04","article-title":"Cyclin-dependent kinase-9: an RNAPII kinase at the nexus of cardiac growth and death cascades","volume":"95","author":"Sano","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0170","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1038\/sj.emboj.7600275","article-title":"Binding of the 7SK snRNA turns the HEXIM1 protein into a P-TEFb (CDK9\/cyclin T) inhibitor","volume":"23","author":"Michels","year":"2004","journal-title":"EMBO J"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0175","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/CIRCRESAHA.107.157859","article-title":"Mutation of the HEXIM1 gene results in defects during heart and vascular development partly through downregulation of vascular endothelial growth factor","volume":"102","author":"Montano","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0180","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cardiores.2007.03.019","article-title":"Pivotal role of cardiac lineage protein-1 (CLP-1) in transcriptional elongation factor P-TEFb complex formation in cardiac hypertrophy","volume":"75","author":"Espinoza-Derout","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0185","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1161\/CIRCRESAHA.108.191726","article-title":"Positive transcription elongation factor b activity in compensatory myocardial hypertrophy is regulated by cardiac lineage protein-1","volume":"104","author":"Espinoza-Derout","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0190","doi-asserted-by":"crossref","first-page":"13084","DOI":"10.1074\/jbc.M111.288944","article-title":"Cardiac lineage protein-1 (CLP-1) regulates cardiac remodeling via transcriptional modulation of diverse hypertrophic and fibrotic responses and angiotensin II-transforming growth factor beta (TGF-beta1) signaling axis","volume":"287","author":"Mascareno","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0195","doi-asserted-by":"crossref","first-page":"e52522","DOI":"10.1371\/journal.pone.0052522","article-title":"Cardiomyocyte-specific overexpression of HEXIM1 prevents right ventricular hypertrophy in hypoxia-induced pulmonary hypertension in mice","volume":"7","author":"Yoshikawa","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0200","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/cvr\/cvt086","article-title":"Inducible re-expression of HEXIM1 causes physiological cardiac hypertrophy in the adult mouse","volume":"99","author":"Montano","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0205","doi-asserted-by":"crossref","first-page":"12655","DOI":"10.1073\/pnas.1220136110","article-title":"CTIP2 is a negative regulator of P-TEFb","volume":"110","author":"Cherrier","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0210","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.yjmcc.2013.07.017","article-title":"BET acetyl-lysine binding proteins control pathological cardiac hypertrophy","volume":"63","author":"Spiltoir","year":"2013","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0215","doi-asserted-by":"crossref","first-page":"13690","DOI":"10.1073\/pnas.0705053104","article-title":"Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription","volume":"104","author":"Bisgrove","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0220","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.molcel.2005.06.027","article-title":"The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription","volume":"19","author":"Jang","year":"2005","journal-title":"Mol Cell"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0225","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.molcel.2005.06.029","article-title":"Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4","volume":"19","author":"Yang","year":"2005","journal-title":"Mol Cell"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0230","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1128\/MCB.22.11.3794-3802.2002","article-title":"Growth and early postimplantation defects in mice deficient for the bromodomain-containing protein Brd4","volume":"22","author":"Houzelstein","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0235","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"Filippakopoulos","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0240","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.cell.2012.03.029","article-title":"A cardiac microRNA governs systemic energy homeostasis by regulation of MED13","volume":"49","author":"Grueter","year":"2012","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.yjmcc.2014.05.002_bb0245","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.celrep.2014.02.028","article-title":"Negative elongation factor controls energy homeostasis in cardiomyocytes","volume":"7","author":"Pan","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0250","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev-pharmtox-010611-134712","article-title":"Therapeutic potential for HDAC inhibitors in the heart","volume":"52","author":"McKinsey","year":"2012","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0255","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/MOL.0000000000000018","article-title":"Pharmacological interventions in human HDL metabolism","volume":"24","author":"Balder","year":"2013","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.yjmcc.2014.05.002_bb0260","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/nyas.12356","article-title":"Targeting epigenetic regulators for cancer therapy","volume":"1309","author":"Wee","year":"2014","journal-title":"Ann N Y Acad Sci"}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282814001552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282814001552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T20:22:51Z","timestamp":1758313371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282814001552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":52,"alternative-id":["S0022282814001552"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2014.05.002","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BET-ting on chromatin-based therapeutics for heart failure","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2014.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}